WCN’22 Industry Symposia

Recorded On: 02/21/2022

  1. HIF-PH Inhibitors - a Novel Option for Anemia Management-Expectations and Potential Concerns
  2. Vascular Calcification in CKD - The Hidden Threat
  3. A focus on IgAN - evolving challenges and therapeutic advances
  4. Water quality for hemodialysis: An urgent need in developing economies to ensure patient safety
  5. The evidence-based CKD clinic: Changing practice with SGLT2 inhibition
  6. Shortening the Path to an aTTP Diagnosis in the Nephrology Clinical Setting
  7. PROs in practice: how and why you should consider adding patient reported outcomes to your routine C
  8. Looking upstream in IgAN: The role of the gut and its implications
  9. New Frontiers in the Treatment of Glomerular Diseases
  10. Dialysis treatment trends from a global perspective
  11. Bending the curve of CKD Medicine with SGLT2i
  12. Application of Genetics in the Care of Kidney Patients
  13. Super High Flux Dialyzer and Mortality in Hemodialysis Patients
  14. Non-steroidal MRAs: Expanding the evidence-base in CKD and T2D and exploring new opportunities
  15. The Link Between Endothelin-1, Angiotensin II, and Proteinuria in the Pathophysiology of CKD
  16. The International Patient and Provider Voice in IgA Nephropathy
  17. Addressing the unmet needs in complement-mediated kidney diseases
  18. Controversies in hyperkalaemia management and practical approaches
  19. A Discussion with KDIGO: Advancing Evidence-Based Care in Diabetes and CKD

Key:

Complete
Failed
Available
Locked
HIF-PH Inhibitors - a Novel Option for Anemia Management-Expectations and Potential Concerns
Open to view video.
Open to view video.
Vascular Calcification in CKD - The Hidden Threat
Open to view video.
Open to view video.
A Focus on IgAN - Evolving Challenges and Therapeutic Advances
Open to view video.
Open to view video.
Water Quality for Hemodialysis: An Urgent Need in Developing Economies to Ensure Patient Safety
Open to view video.
Open to view video.
The Evidence-based CKD Clinic: Changing Practice with SGLT2 Inhibition
Open to view video.
Open to view video.
Shortening the Path to an aTTP Diagnosis in the Nephrology Clinical Setting
Open to view video.
Open to view video.
PROs in Practice: How and Why You Should Consider Adding Patient Reported Outcomes to Your Routine C
Open to view video.
Open to view video.
Looking Upstream in IgAN: The Role of the Gut and its Implications
Open to view video.
Open to view video.
New Frontiers in the Treatment of Glomerular Diseases
Open to view video.
Open to view video.
Dialysis Treatment Trends From a Global Perspective
Open to view video.
Open to view video.
Bending the Curve of CKD Medicine with SGLT2i
Open to view video.
Open to view video.
Application of Genetics in the Care of Kidney Patients
Open to view video.
Open to view video.
Super High Flux Dialyzer and Mortality in Hemodialysis Patients
Open to view video.
Open to view video.
Non-steroidal MRAs: Expanding the Evidence-base in CKD and T2D and Exploring New Opportunities
Open to view video.
Open to view video.
The Link Between Endothelin-1, Angiotensin II, and Proteinuria in the Pathophysiology of CKD
Open to view video.
Open to view video.
The International Patient and Provider Voice in IgA Nephropathy
Open to view video.
Open to view video.
Addressing the Unmet Needs in Complement-mediated Kidney Diseases
Open to view video.
Open to view video.
Controversies in Hyperkalaemia Management and Practical Approaches
Open to view video.
Open to view video.
A Discussion with KDIGO: Advancing Evidence-Based Care in Diabetes and CKD
Open to view video.
Open to view video.